98757000

Information

• Trademark
• 98757000

• Source

• Serial Number

  98757000

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 41 - Education
  • 44 - Medical services

• Filing Date

  September 18, 2024
  6 months ago

• Transaction Date

  March 26, 2025
  2 days ago

• Status Date

  September 18, 2024
  6 months ago

• Location Date

  March 25, 2025
  3 days ago

• Status Code

  630

• Attorney Name

  Maury M. Tepper, III

• Owners

  • SAREPTA THERAPEUTICS, INC.

Case File Statements

• GS0411: Medical training and teaching
• DM0000: The mark consists of three alternately-shaded semi-circles increasing in size to an oval center and three alternately-shaded semi-circles decreasing in size on the other side of the oval center. The color gray is intended to show shading or contract only.
• GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
• CC0000: Color is not claimed as a feature of the mark.
• GS0441: Medical services; providing health information

Case File Event Statements

• 9/18/2024 - 6 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP